文献速递胸部肿瘤

基于完整肺癌家族史的肺癌人群相对风险研究

Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2019-05-07

共识别5048例肺癌病例,一级亲属、二级亲属和三级亲属中肺癌患者数量增加均与肺癌风险显著升高相关,一级亲属患肺癌时RR从2.57至4.24,二级亲属从1.41至4.76,三级亲属从1.18至1.55,且一级亲属诊断年龄越早风险越高,母系与父系家族史风险相当。

要点

  • 一级亲属患肺癌者RR为2.57(95%CI 2.39-2.76),3个及以上一级亲属患肺癌者RR为4.24(95%CI 1.56-9.23)。
  • 无一级亲属家族史时,1个及以上二级亲属患肺癌者RR为1.41(95%CI 1.30-1.52),4个及以上二级亲属者RR为4.76(95%CI 1.55-11.11)。
  • 无一级和二级亲属家族史时,1个及以上三级亲属患肺癌者RR为1.18(95%CI 1.11-1.24),4个及以上三级亲属者RR为1.55(95%CI 1.03-2.24)。

核心结论

  • 该研究基于先证者完整肺癌家族史模式提供了人群水平的肺癌风险估计,识别出许多肺癌风险增加2至5倍或以上的个体。
  • 基于家族史的肺癌相对风险估计在临床上具有相关性,所提出的家族史模式RR估计可用于个体决策以指导肺癌筛查的资源使用,并可能在筛查、治疗和治后监测决策中起关键作用。

研究设计与样本

  • 研究利用基于人群的家谱资源链接至全州电子监测流行病学与最终结果计划癌症登记系统,基于个体肺癌家族史估算肺癌相对风险。
  • 先证者家族史数据包括亲属关系等级(一级至三级)、父系或母系肺癌家族史、患肺癌亲属数量及受累亲属诊断年龄。

主要发现

  • 共识别5048例肺癌病例。
  • 一级、二级或三级亲属中任何数量的肺癌受累亲属均观察到RR显著升高。
  • 每增加一名肺癌一级亲属,RR显著升高,从1个及以上一级亲属的RR=2.57(95%CI 2.39-2.76)至3个及以上一级亲属的RR=4.24(95%CI 1.56-9.23)。
  • 无一级亲属家族史时,随着受累二级亲属数量增加,肺癌风险显著增加,从1个及以上二级亲属的1.41(95%CI 1.30-1.52)至4个及以上二级亲属的4.76(95%CI 1.55-11.11)。
  • 无一级和二级亲属受累时,基于肺癌受累三级亲属的风险显著增加,从1个及以上三级亲属的1.18(95%CI 1.11-1.24)至4个及以上三级亲属的1.55(95%CI 1.03-2.24)。

关键数值与推荐

  • 1个及以上一级亲属患肺癌:RR=2.57(95%CI 2.39-2.76)。
  • 3个及以上一级亲属患肺癌:RR=4.24(95%CI 1.56-9.23)。
  • 无一级亲属家族史时,1个及以上二级亲属患肺癌:RR=1.41(95%CI 1.30-1.52);4个及以上二级亲属患肺癌:RR=4.76(95%CI 1.55-11.11)。
  • 无一级和二级亲属家族史时,1个及以上三级亲属患肺癌:RR=1.18(95%CI 1.11-1.24);4个及以上三级亲属患肺癌:RR=1.55(95%CI 1.03-2.24)。

临床怎么用

  • 原文结论指出,基于家族史的肺癌相对风险估计在临床上具有相关性,所提出的家族史模式RR估计可用于个体决策以指导肺癌筛查的资源使用。
  • 原文结论指出,该家族史模式RR估计可能在筛查、治疗和治后监测决策中起关键作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Published risk estimates for diagnosis of lung cancer based on family history are typically focused on close relatives, rather than a more diverse or complete family history. This study provides estimates of relative risk (RR) for lung cancer based on comprehensive family history data obtained from a statewide cancer registry linked to a high-quality genealogy data resource that is extensive and deep. The risk estimates presented avoid common recall, recruitment, ascertainment biases, and are based on an individual's (proband's) lung cancer family history constellation (pattern of lung cancer affected relatives); numerous constellations are explored. METHODS: We used a population-based genealogic resource linked to a statewide electronic Surveillance Epidemiology and End Results program cancer registry to estimate RR for lung cancer for an individual based on their lung cancer family history. The family history data available for a proband included degree of relationship (first- to third-degree), paternal or maternal family lung cancer history, number of lung cancer-affected relatives, and age at diagnosis of affected relatives. More than 1.3 million probands with specific constellations of lung cancer were analyzed. To estimate RRs for lung cancer, the observed number of lung cancer cases among probands with a specific family history constellation was compared to the expected number using internal cohort-specific rates. RESULTS: A total of 5048 lung cancer cases were identified. Significantly elevated RR was observed for any number of lung cancer-affected relatives among first-, second-, or third-degree relatives. RRs for lung cancer were significantly elevated for each additional lung cancer first-degree relative (FDR) ranging from RR = 2.57 (confidence interval [CI] 95%: 2.39, 2.76) for 1 or more FDR to RR = 4.24 (CI 95%: 1.56, 9.23) for 3 or more FDRs affected. In an absence of FDR family history, increased risk for lung cancer was significant for increasing numbers of affected second-degree relatives (SDRs) ranging from 1.41 (CI 95%: 1.30, 1.52) for 1 or more SDRs to 4.76 (CI 95%: 1.55, 11.11) for 4 or more SDRs. In the absence of affected FDRs and SDRs, there were significantly increased risks based on lung cancer-affected third-degree relatives (TDRs) ranging from 1.18 (CI 95%: 1.11, 1.24) for 1 or more affected TDRs to 1.55 (CI 95%: 1.03, 2.24) for 4 or more affected TDRs. RRs were significantly increased with earlier age at diagnosis of a FDR, and equivalent risks for maternal compared to paternal history were observed. CONCLUSIONS: This study provides population-based estimates of lung cancer risk based on a proband's complete family history (lung cancer constellation). Many individuals at two to five or more times increased risk for lung cancer are identified. Estimates of RR for lung cancer based on family history are arguably relevant clinically. The constellation RR estimates presented could serve in individual decision-making to direct resource use for lung cancer screening, and could be pivotal in decision-making for screening, treatment, and post-treatment surveillance.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Cannon-Albright LA, Carr SR, Akerley W, et al. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer. J Thorac Oncol. 2019. PMID: 31075544. doi:10.1016/j.jtho.2019.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。